| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/08/2023 | 1.67% | Wells Fargo | $88 → $89 | Maintains | Equal-Weight |
| 10/18/2023 | 8.52% | Morgan Stanley | $89 → $95 | Maintains | Equal-Weight |
| 08/03/2023 | 1.67% | Morgan Stanley | $84 → $89 | Maintains | Equal-Weight |
| 08/03/2023 | 1.67% | Goldman Sachs | $78 → $89 | Maintains | Neutral |
| 08/02/2023 | 16.52% | JP Morgan | $96 → $102 | Maintains | Overweight |
| 08/02/2023 | 1.67% | Goldman Sachs | $78 → $89 | Maintains | Neutral |
| 08/02/2023 | 10.81% | Oppenheimer | $93 → $97 | Maintains | Outperform |
| 08/02/2023 | -0.62% | Wells Fargo | $77 → $87 | Maintains | Equal-Weight |
| 07/19/2023 | 0.53% | UBS | $75 → $88 | Maintains | Neutral |
| 07/18/2023 | -4.04% | Morgan Stanley | $77 → $84 | Maintains | Equal-Weight |
| 07/11/2023 | -12.04% | Wells Fargo | $71 → $77 | Maintains | Equal-Weight |
| 05/30/2023 | -12.04% | Morgan Stanley | $78 → $77 | Maintains | Equal-Weight |
| 05/30/2023 | -8.61% | Keefe, Bruyette & Woods | $81 → $80 | Reiterates | Market Perform → Market Perform |
| 05/26/2023 | -7.47% | JP Morgan | $85 → $81 | Maintains | Overweight |
| 05/26/2023 | -0.62% | Oppenheimer | → $87 | Upgrades | Perform → Outperform |
| 05/26/2023 | -18.89% | Wells Fargo | $73 → $71 | Maintains | Equal-Weight |
| 05/26/2023 | -8.61% | Keefe, Bruyette & Woods | $81 → $80 | Maintains | Market Perform |
| 04/18/2023 | -7.47% | Keefe, Bruyette & Woods | $85 → $81 | Maintains | Market Perform |
| 03/15/2023 | -2.9% | JP Morgan | → $85 | Upgrades | Neutral → Overweight |
| 02/09/2023 | -8.61% | Goldman Sachs | $70 → $80 | Maintains | Neutral |
| 02/09/2023 | -10.9% | Morgan Stanley | $72 → $78 | Maintains | Equal-Weight |
| 02/08/2023 | -2.9% | JP Morgan | $86 → $85 | Maintains | Neutral |
| 02/08/2023 | -14.32% | Wells Fargo | $69 → $75 | Maintains | Equal-Weight |
| 01/24/2023 | -17.75% | Morgan Stanley | $67 → $72 | Maintains | Equal-Weight |
| 01/11/2023 | -21.18% | Wells Fargo | $65 → $69 | Maintains | Equal-Weight |
| 10/19/2022 | -22.32% | UBS | $75 → $68 | Maintains | Neutral |
| 10/19/2022 | -23.46% | Morgan Stanley | $72 → $67 | Maintains | Equal-Weight |
| 08/09/2022 | -17.75% | Morgan Stanley | $73 → $72 | Maintains | Equal-Weight |
| 08/09/2022 | -14.32% | UBS | $72 → $75 | Downgrades | Buy → Neutral |
| 07/19/2022 | -16.61% | Morgan Stanley | $92 → $73 | Maintains | Equal-Weight |
| 07/13/2022 | -17.75% | Wells Fargo | $74 → $72 | Maintains | Equal-Weight |
| 06/29/2022 | -13.18% | Goldman Sachs | $85 → $76 | Maintains | Neutral |
| 06/01/2022 | 5.09% | Morgan Stanley | $101 → $92 | Maintains | Equal-Weight |
| 04/20/2022 | 15.38% | Morgan Stanley | $111 → $101 | Maintains | Equal-Weight |
| 04/19/2022 | -10.9% | Wells Fargo | $95 → $78 | Maintains | Equal-Weight |
| 01/21/2022 | 26.8% | Morgan Stanley | $120 → $111 | Maintains | Equal-Weight |
| 12/16/2021 | 24.51% | Wells Fargo | → $109 | Initiates Coverage On | → Equal-Weight |
| 10/15/2021 | 15.38% | Morgan Stanley | $98 → $101 | Maintains | Equal-Weight |
| 08/04/2021 | 11.95% | Morgan Stanley | $97 → $98 | Maintains | Equal-Weight |
| 05/28/2021 | 10.81% | Morgan Stanley | $96 → $97 | Maintains | Equal-Weight |
| 04/16/2021 | 9.66% | Morgan Stanley | $88 → $96 | Maintains | Equal-Weight |
| 02/04/2021 | 0.53% | Morgan Stanley | $90 → $88 | Maintains | Equal-Weight |
| 01/26/2021 | — | Morgan Stanley | Downgrades | Overweight → Equal-Weight | |
| 10/20/2020 | -4.04% | Morgan Stanley | $80 → $84 | Maintains | Overweight |
| 07/14/2020 | -8.61% | Morgan Stanley | $74 → $80 | Maintains | Overweight |
| 06/11/2020 | -15.47% | Morgan Stanley | $70 → $74 | Maintains | Overweight |
| 05/13/2020 | -24.61% | Wells Fargo | $60 → $66 | Maintains | Equal-Weight |
| 04/17/2020 | -20.04% | Morgan Stanley | $75 → $70 | Maintains | Overweight |
| 04/15/2020 | -31.46% | Wells Fargo | $68 → $60 | Maintains | Equal-Weight |
| 03/30/2020 | -36.03% | Keefe, Bruyette & Woods | $61 → $56 | Upgrades | Underperform → Market Perform |
| 02/07/2020 | — | William Blair | Initiates Coverage On | → Outperform | |
| 01/23/2020 | -13.18% | Morgan Stanley | $66 → $76 | Maintains | Overweight |
| 01/17/2020 | -22.32% | Wells Fargo | $62 → $68 | Maintains | Equal-Weight |
| 09/12/2019 | -31.46% | Wells Fargo | $58 → $60 | Maintains | Market Perform |
| 07/11/2019 | — | Keefe, Bruyette & Woods | Downgrades | Market Perform → Underperform | |
| 06/25/2019 | — | Oppenheimer | Initiates Coverage On | → Perform | |
| 05/31/2019 | -31.46% | Morgan Stanley | $56 → $60 | Maintains | Overweight |
| 04/11/2019 | — | Morgan Stanley | Upgrades | Equal-Weight → Overweight | |
| 11/14/2018 | -50.88% | Morgan Stanley | $48 → $43 | Maintains | Equal-Weight |
What is the target price for Hamilton Lane (HLNE)?
The latest price target for Hamilton Lane (NASDAQ: HLNE) was reported by Wells Fargo on November 8, 2023. The analyst firm set a price target for $89.00 expecting HLNE to rise to within 12 months (a possible 1.67% upside). 25 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Hamilton Lane (HLNE)?
The latest analyst rating for Hamilton Lane (NASDAQ: HLNE) was provided by Wells Fargo, and Hamilton Lane maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Hamilton Lane (HLNE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hamilton Lane, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hamilton Lane was filed on November 8, 2023 so you should expect the next rating to be made available sometime around November 8, 2024.
Is the Analyst Rating Hamilton Lane (HLNE) correct?
While ratings are subjective and will change, the latest Hamilton Lane (HLNE) rating was a maintained with a price target of $88.00 to $89.00. The current price Hamilton Lane (HLNE) is trading at is $87.54, which is out of the analyst's predicted range.